Bluebirdbio stock.

bluebird bio. bluebird bio received FDA accelerated approval for SKYSONA® (elivaldogene autotemcel) gene therapy for early, active cerebral adrenoleukodystrophy (CALD). SKYSONA is the first FDA approved therapy shown to slow the progression of neurologic dysfunction in boys with this devastating and fatal neurodegenerative disease.bluebird bio, Inc., based in Somerville, Massachusetts, is a biotechnology company that develops gene therapies for severe genetic disorders. The company's only - in the European Union (EU) - approved drug is betibeglogene autotemcel (Zynteglo), which treats transfusion-dependent beta thalassemia (TDT), a rare genetic blood disorder, and has been approved for use by the European Medicines Agency.Nov 8, 2021 · Shares of Bluebird Bio ( BLUE 2.64%) were plunging 19.3% lower as of 3:42 p.m. EST on Monday. The sharp decline came after two analysts downgraded Bluebird. Goldman Sachs ( GS 0.15%) analyst ... bluebird bio Stock Up 11.5 % NASDAQ BLUE traded up $0.44 during trading on Friday, reaching $4.26. 5,100,895 shares of the stock traded hands, compared to its average volume of 4,113,761.1h. Shares of bluebird bio BLUE have increased by 25.6% in a month compared with the industry’s growth of 0.2%. Last month, bluebird posted better-than-expected results in the third quarter. It ...

Overview Corporate Governance Press Releases Events & Presentations Analyst Coverage Stock Information SEC Filings Investor FAQs Toolkit Annual Meeting …Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...

Bluebird bio's blood disorder treatment demonstrates "clinically meaningful" benefit in patients, staff reviewers at the U.S. Food and Drug Administration said in briefing documents published on ...bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and SKYSONA (elivaldogene autotemcel ...

Bluebird bio Inc (NASDAQ: BLUE)’s stock price has gone rise by 3.95 in comparison to its previous close of 3.79, however, the company has experienced a 29.60% increase in its stock price over the last five trading days. The Motley Fool reported 2023-11-26 that Biotech stocks with major catalysts can be powerful capital appreciation …Bluebird Bio has a market capitalization of around $425 million at the moment, so this small-cap biotech stock could see a significant increase in its share …The last 12 months haven't been kind to the likes of gene editing stocks like CRISPR Therapeutics (CRSP 2.88%) and Bluebird Bio (BLUE 11.52%). Whereas CRISPR's shares fell by 31%, Bluebird's are ...As at March 2023, bluebird bio had cash of US$318m and no debt. In the last year, its cash burn was US$328m. Therefore, from March 2023 it had roughly 12 months of cash runway. To be frank, this ...

SOMERVILLE, Mass., March 29, 2023--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today reported financial results and business highlights for the fourth quarter and full year ...

Find the latest bluebird bio, Inc. (BLUE) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

November 04, 2021 07:00 AM Eastern Daylight Time. CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- bluebird bio, Inc. (NASDAQ: BLUE) today announced the company has completed the tax-free spin-off of its ...Nov 26, 2023 · Get bluebird bio Inc (BLUE.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments bluebird bio, Inc. is a clinical-stage biotechnology company ... Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only.Nick Leschly is heading up bluebird bio spinout 2seventy bio as CEO. Eleven months after announcing the split, bluebird bio Inc. has finished the separation of its cancer business. The oncology ...Key Points. Bluebird Bio will continue the launch of two newly commercialized therapies. The small-cap biotech is also seeking another key approval this year. But it faces a number of risks that ...

Bluebird Bio could soon earn approval for two key gene-editing therapies. However, the company does face severe financial troubles. Bluebird's stock is risky, but the rewards could be huge. Motley ...The current stock price for Safety Shot Inc (SHOT) is $5.80. The stock experienced a significant increase during the last trading session, reaching $5.20 after opening at $4.40. It dipped to a low of $4.3597 before ultimately closing at $4.85. Top 5 EV Tech Stocks to Buy for 2023. The electric vehicle boom is accelerating – and fast.bluebird bio ( BLUE 0.52%) is a biotech company that specializes in gene editing, a technology that allows scientists to modify the genetic material of living organisms. Gene editing has the ...Bluebird Bio has a market capitalization of around $425 million at the moment, so this small-cap biotech stock could see a significant increase in its share price if it lands this historic approval.Bluebird Bio has a market capitalization of around $425 million at the moment, so this small-cap biotech stock could see a significant increase in its share price if it lands this historic approval.

Find the latest 2seventy bio, Inc. (TSVT) stock quote, history, news and other vital information to help you with your stock trading and investing.See bluebird bio, Inc. (BLUE) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

Nov 29, 2023 · See the latest bluebird bio Inc stock price (BLUE:XNAS), related news, valuation, dividends and more to help you make your investing decisions. bluebird bio Inc (BLUE) stock is higher by 0.26% while the S&P 500 is down -0.11% as of 11:47 AM on Thursday, Nov 30. BLUE has risen $0.01 from the previous closing price of $3.86 on volume of 1,460,801 shares. Over the past year the S&P 500 is up 14.86% while BLUE is down -49.41%. BLUE lost -$0.74 per share in the over the last 12 …You can submit queries to bluebird bio’s investor relations department by contacting 617-245-2107 or [email protected]. Show All Spinoff Stock Distributionbluebird bio, Inc. (BLUE) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. As of 03:57PM EST. Market open. See bluebird bio, Inc. (BLUE) stock analyst estimates, including earnings and ...Apr 22, 2022 · Bluebird Bio’s Weak Cash Position. Bluebird Bio’s stock trades a whopping 98% below its March 2018 peak and has lost 80% of its value since going public in June 2013. The company was ... Bluebird stock slides as company delays sickle-cell drug. Andrew Obenshain is the CEO of bluebird bio. After its split into two companies — one focused on gene therapy, the other on cancer ...Aug 9, 2021 · Shares of Bluebird Bio ( BLUE -0.78%) were crashing 23.3% lower as of 12:18 p.m. EDT on Monday. The big decline came after the company announced two negative developments in its second-quarter ... Overview Corporate Governance Press Releases Events & Presentations Analyst Coverage Stock Information SEC Filings Investor FAQs Toolkit Annual Meeting …bluebird bio Inc. Watch NEW Set a price target alert Open Last Updated: Nov 27, 2023 1:11 p.m. EST Real time quote $ 3.7650 -0.1250 -3.21% Previous Close $3.8900 Advanced Charting Volume: 2.77M...The past several years have been brutal for biotech company Bluebird bio (BLUE 1.34%).Shares of the gene-editing specialist are down by 85% since early 2020 as it has had to deal with clinical and ...

bluebird bio specializes in gene therapies for severe genetic diseases and has 2 FDA-approved products. EV/Sales multiple appears cheap. Find out why BLUE …

On average, Wall Street analysts predict. that Bluebird Bio's share price could reach $7.64 by Nov 8, 2024. The average Bluebird Bio stock price prediction forecasts a potential upside of 96.45% from the current BLUE share price of $3.89.

Bluebird stock slides as company delays sickle-cell drug. Andrew Obenshain is the CEO of bluebird bio. After its split into two companies — one focused on gene therapy, the other on cancer [email protected]. Investor Contacts. Courtney O’Leary. Investor Relations (978) 621-7347. [email protected]. stock quote stock sub menu. Stock Quote; Stock Chart (Common Stock) Exchange (US Dollar) Price: Change (%) Volume: Today's Open: Previous Close: Intraday High: Intraday Low:Nov 28, 2022 · bluebird bio has received approval for their first products and are on track to treat their first patient later this year. Find out why BLUE stock is a hold. bluebird bio (BLUE) added ~8% pre-market Wednesday after Bank of America upgraded the stock, citing potential FDA approval for its SCD therapy lovo-cel. Read more here.Bluebird bio Inc (NASDAQ: BLUE)’s stock price has gone rise by 3.95 in comparison to its previous close of 3.79, however, the company has experienced a 29.60% increase in its stock price over the last five trading days. The Motley Fool reported 2023-11-26 that Biotech stocks with major catalysts can be powerful capital appreciation …Nov 4, 2023 · Bluebird Bio has experienced a barrage of issues in the past five years. The biotech has a potential approval on the way that could help it rebound. Even so, the company remains a risky stock to ... The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.Bristol Myers Squibb (NYSE: BMY) and bluebird bio, Inc. (Nasdaq: BLUE) today announced that the U.S. Food and Drug Administration (FDA) has approved Abecma (idecabtagene vicleucel; ide-cel) as the first B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T cell immunotherapy for the treatment of adult patients …

Jul 19, 2023 · Pgiam/iStock via Getty Images. bluebird bio ( NASDAQ: BLUE) added ~8% pre-market Wednesday after Bank of America upgraded the stock to Buy from Neutral, citing a potential FDA approval for its new ... The current price bluebird bio (BLUE) is trading at is $3.87, which is out of the analyst’s predicted range. Browse analyst ratings and price targets on all stocks. Popular ChannelsMay 21, 2020 · CAMBRIDGE, Mass. -- (BUSINESS WIRE)--May 18, 2020-- bluebird bio, Inc. (Nasdaq: BLUE) today announced the pricing of an underwritten public offering of 9,090,910 shares of its common stock at a public offering price of $55.00 per share, before underwriting discounts. In addition, bluebird bio has granted the underwriters a 30-day option to ... Instagram:https://instagram. iso20022 tokenswhat's the best investment companybed bath and beyond stocktwitswhat reit pays the highest dividend http://www.bluebirdbio.com. External link for bluebird bio. Industry: Biotechnology ... Stock. BLUE. December 2, 2023. NASDAQ. 20 minutes delay. $4.26. 0.44 ( ... who buy broken iphonesrobin hood extended hours Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t... nasdaq aapl dividend Shares of Bluebird Bio ( BLUE 0.61%) were sinking 10.4% this week as of the market close on Thursday, according to data from S&P Global Market Intelligence. The decline came after the company ...Here's why. BLUE data by YCharts. 1. Bluebird Bio. To say that Bluebird Bio has lagged the market in the past year would be an understatement. The gene-editing specialist has lost over 70% of its ...